Cargando…
Formyl peptide receptor type 2 agonists to kick‐start resolution pharmacology
One way to develop innovative approaches for the treatment of chronic diseases is to exploit the biology of the resolution of inflammation. With this terminology, we identify the integrated and complex network of mediators and pathways that ensure a timely and spatially regulated inflammatory respon...
Autores principales: | Perretti, Mauro, Godson, Catherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520433/ https://www.ncbi.nlm.nih.gov/pubmed/32954491 http://dx.doi.org/10.1111/bph.15212 |
Ejemplares similares
-
Antiflammin-2 Activates the Human Formyl-Peptide Receptor Like 1
por: Kamal, Ahmad M., et al.
Publicado: (2006) -
Formyl Peptide Receptor Type 2 Deficiency in Myeloid Cells Amplifies Sepsis-Induced Cardiac Dysfunction
por: Chen, Jianmin, et al.
Publicado: (2023) -
Formyl Peptide Receptor as a Novel Therapeutic Target for Anxiety-Related Disorders
por: Gallo, Irene, et al.
Publicado: (2014) -
Glucagon‐like peptide‐1 receptor agonists for type 2 diabetes: A rational drug development
por: Ahrén, Bo
Publicado: (2018) -
XQuery: kick start
por: McGovern, James, et al.
Publicado: (2004)